| Stage | DVN | % of rev | ENB | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $6.9B | 100.00% | $14.8B | 100.00% | ENB ×2.16 |
| Gross profit | $3.4B | 48.89% | $4.3B | 28.91% | DVN +20.0pp |
| Operating income | $1.4B | 20.51% | $1.5B | 10.14% | DVN +10.4pp |
| Pre-tax income | $1.3B | 18.25% | $1.3B | 8.91% | DVN +9.3pp |
| Net income | $1.0B | 14.69% | $1.0B | 6.84% | DVN +7.9pp |
| Stage | DVN | ENB | Gap · A − B |
|---|---|---|---|
| Revenue | $6.9B100.00% | $14.8B100.00% | ENB ×2.16 |
| Gross profit | 48.89%$3.4B | 28.91%$4.3B | DVN +20.0pp |
| Operating income | 20.51%$1.4B | 10.14%$1.5B | DVN +10.4pp |
| Pre-tax income | 18.25%$1.3B | 8.91%$1.3B | DVN +9.3pp |
| Net income |
| 14.69%$1.0B |
| 6.84%$1.0B |
| DVN +7.9pp |
None
No disclosed counterparties: DVN.